Hidenori Ando Selected Research

DFP-10825

1/2020	An RNAi therapeutic, DFP-10825, for intraperitoneal and intrapleural malignant cancers.
12/2019	A novel intraperitoneal therapy for gastric cancer with DFP-10825, a unique RNAi therapeutic targeting thymidylate synthase, in a peritoneally disseminated xenograft model.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hidenori Ando Research Topics

Disease

44	Neoplasms (Cancer) 01/2024 - 01/2012
4	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 09/2017
3	Ovarian Neoplasms (Ovarian Cancer) 07/2023 - 12/2019
3	Pancreatic Neoplasms (Pancreatic Cancer) 07/2023 - 01/2021
3	Stomach Neoplasms (Stomach Cancer) 06/2021 - 12/2019
3	Mesothelioma 04/2020 - 12/2015
3	Malignant Mesothelioma 04/2020 - 12/2015
3	Neoplasm Metastasis (Metastasis) 12/2019 - 01/2012
2	Hypersensitivity (Allergy) 01/2024 - 11/2022
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 07/2023 - 01/2022
2	Ascites 01/2022 - 06/2019
2	Neutropenia 01/2022 - 07/2020
2	Autoimmune Diseases (Autoimmune Disease) 05/2021 - 01/2018
2	Systemic Lupus Erythematosus (Libman-Sacks Disease) 05/2021 - 01/2018
2	Experimental Melanoma 01/2021 - 01/2012
2	Liver Neoplasms (Liver Cancer) 01/2016 - 01/2016
2	Melanoma (Melanoma, Malignant) 01/2015 - 01/2013
1	Leukemia 07/2023
1	Fever (Fevers) 01/2023
1	Lewis Lung Carcinoma 01/2023
1	Triple Negative Breast Neoplasms 01/2023
1	Wilms Tumor (Wilm's Tumor) 01/2023
1	Atherosclerotic Plaque (Atheroma) 11/2022
1	Atherosclerosis 11/2022
1	Multiple Sclerosis 11/2022
1	Carcinogenesis 11/2022
1	COVID-19 11/2022
1	Tumor Lysis Syndrome 01/2022
1	Communicable Diseases (Infectious Diseases) 01/2022
1	Chronic Disease (Chronic Diseases) 01/2022
1	Lupus Nephritis 05/2021
1	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 05/2021

Drug/Important Bio-Agent (IBA)

22	Liposomes (Liposome)IBA 01/2023 - 01/2013
11	Small Interfering RNA (siRNA)IBA 01/2023 - 01/2013
7	Therapeutic UsesIBA 01/2023 - 05/2014
6	Immunoglobulin M (IgM)IBA 01/2024 - 01/2018
6	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 07/2023 - 01/2013
6	Proteins (Proteins, Gene)FDA Link 01/2022 - 05/2014
5	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2022 - 12/2015
5	Triethylenephosphoramide (TEPA)IBA 01/2016 - 01/2012
4	Doxorubicin (Adriamycin)FDA LinkGeneric 08/2021 - 01/2016
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2016 - 01/2012
3	liposomal doxorubicin (Doxil)FDA Link 01/2024 - 12/2017
3	Peptides (Polypeptides)IBA 01/2023 - 01/2013
3	AlbuminsIBA 01/2022 - 01/2021
3	PlatinumIBA 01/2022 - 01/2018
3	Antineoplastic Agents (Antineoplastics)IBA 08/2021 - 01/2021
3	Paclitaxel (Taxol)FDA LinkGeneric 06/2021 - 03/2021
3	Thymidylate SynthaseIBA 01/2020 - 10/2017
2	COVID-19 VaccinesIBA 01/2024 - 11/2022
2	AntibodiesIBA 01/2024 - 05/2021
2	RNA (Ribonucleic Acid)IBA 01/2023 - 04/2020
2	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2023 - 07/2020
2	VaccinesIBA 01/2023 - 01/2022
2	AntigensIBA 01/2023 - 01/2018
2	LipidsIBA 11/2022 - 12/2015
2	Lipid NanoparticlesIBA 11/2022 - 07/2014
2	LuciferasesIBA 01/2022 - 04/2020
2	CelluloseIBA 06/2021 - 03/2021
2	Albumin-Bound Paclitaxel FDA Link 05/2021 - 01/2021
2	DFP-10825IBA 01/2020 - 12/2019
2	Epidermal Growth Factor (EGF)IBA 01/2018 - 07/2014
2	alanyl-prolyl-arginyl-prolyl-glycineIBA 01/2016 - 05/2014
2	tetraethylenepentamineIBA 01/2016 - 01/2013
2	CholesterolIBA 12/2015 - 01/2013
2	arginyl-glycyl-aspartic acidIBA 01/2013 - 01/2012
1	Gemcitabine FDA Link 07/2023
1	DFP-10917IBA 07/2023
1	DeoxycytidineIBA 07/2023
1	Ionic LiquidsIBA 01/2023
1	Immunoglobulin G (IgG)IBA 01/2023
1	resiquimodIBA 01/2023
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 01/2023
1	TensinsIBA 01/2023
1	Toll-Like Receptor 7IBA 01/2023
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2023
1	Fingolimod Hydrochloride (FTY720)FDA Link 11/2022
1	Immunosuppressive Agents (Immunosuppressants)IBA 11/2022
1	Glycoproteins (Glycoprotein)IBA 11/2022
1	mRNA VaccinesIBA 11/2022
1	Messenger RNA (mRNA)IBA 11/2022
1	CytokinesIBA 01/2022
1	venetoclaxIBA 01/2022
1	Blood Proteins (Serum Proteins)IBA 01/2022
1	Nanoparticle Drug Delivery SystemIBA 08/2021
1	Drug CarriersIBA 08/2021
1	ProdrugsIBA 08/2021
1	Human Serum Albumin FDA LinkGeneric 08/2021
1	Nucleic AcidsIBA 05/2021
1	Antigen-Antibody Complex (Immune Complex)IBA 05/2021
1	Cysteine (L-Cysteine)FDA Link 05/2021
1	AcidsIBA 05/2021
1	Albumin ReceptorsIBA 05/2021
1	Indocyanine Green (Cardio-Green)FDA LinkGeneric 05/2021

Therapy/Procedure

12	Therapeutics 01/2024 - 01/2013
6	Drug Therapy (Chemotherapy) 01/2022 - 01/2016
3	Intravenous Injections 07/2023 - 05/2014
3	Intravenous Administration 07/2023 - 01/2016
3	RNAi Therapeutics 01/2020 - 06/2019
2	Oral Administration 10/2022 - 01/2021